Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Hung, MC' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 144 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Lin, SY; Makino, K; Xia, WY; Matin, A; Wen, Y; Kwong, KY; Bourguignon, L; Hung, MC
      Nuclear localization of EGF receptor and its potential new role as a transcription factor

      NATURE CELL BIOLOGY
    2. Zhou, BHP; Liao, Y; Xia, WY; Spohn, B; Lee, NH; Hung, MC
      Cytoplasmic localization of p21(Cip1/WAF1) by Akt-induced phosphorylation in HER-2/neu-overexpressing cells

      NATURE CELL BIOLOGY
    3. Zhou, BHP; Liao, Y; Xia, WY; Zou, YY; Spohn, B; Hung, MC
      HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation

      NATURE CELL BIOLOGY
    4. Yoo, GH; Hung, MC; Lopez-Berestein, G; LaFollette, S; Ensley, JF; Carey, M; Batson, E; Reynolds, TC; Murray, JL
      Phase I trial of intratumoral liposome E1A gene therapy in patients with recurrent breast and head and neck cancer

      CLINICAL CANCER RESEARCH
    5. Zou, YY; Wu, QP; Tansey, W; Chow, D; Hung, MC; Vej, CC; Wallace, S; Li, C
      Effectiveness of water soluble poly(L-glutamic acid)camptothecin conjugateagainst resistant human lung cancer xenografted in nude mice

      INTERNATIONAL JOURNAL OF ONCOLOGY
    6. Wang, SC; Makino, K; Xia, WY; Kim, JS; Im, SA; Peng, H; Mok, SC; Singletary, SE; Hung, MC
      DOC-2/hDab-2 inhibits ILK activity and induces anoikis in breast cancer cells through an Akt-independent pathway

      ONCOGENE
    7. Yang, HY; Shao, RP; Hung, MC; Lee, MH
      p27 Kip1 inhibits HER2/neu-mediated cell growth and tumorigenesis

      ONCOGENE
    8. Makino, K; Yu, DH; Hung, MC
      Transcriptional upregulation and activation of p55Cdc via p34(cdc2) in Taxol-induced apoptosis

      ONCOGENE
    9. Newman, L; Xia, WY; Yang, HY; Sahin, A; Bondy, M; Lukmanji, F; Hung, MC; Lee, MH
      Correlation of p27 protein expression with HER-2/neu expression in breast cancer

      MOLECULAR CARCINOGENESIS
    10. Hortobagyi, GN; Ueno, N; Hung, MC
      E1A is an oncogene and may immortalize normal cells, especially in combination with other oncoproteins - In reply

      JOURNAL OF CLINICAL ONCOLOGY
    11. Hortobagyi, GN; Ueno, NT; Xia, WY; Zhang, S; Wolf, JK; Putnam, JB; Weiden, PL; Willey, JS; Carey, M; Branham, DL; Payne, JY; Tucker, SD; Bartholomeusz, C; Kilbourn, RG; De Jager, RL; Sneige, N; Katz, RL; Anklesaria, P; Ibrahim, NK; Murray, JL; Theriault, RL; Valero, V; Gershenson, DM; Bevers, MW; Huang, L; Lopez-Berestein, G; Hung, MC
      Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: A phase I clinical trial

      JOURNAL OF CLINICAL ONCOLOGY
    12. Wang, SC; Hung, MC
      HER2 overexpression and cancer targeting

      SEMINARS IN ONCOLOGY
    13. Hung, MC; Hayase, K; Yoshida, R; Sato, M; Imaizumi, K
      Cerebral protein kinase C and its mRNA level in apolipoprotein E-deficientmice

      LIFE SCIENCES
    14. Zhou, ZC; Jia, SF; Hung, MC; Kleinerman, ES
      E1A sensitizes HER2/neu-overexpressing Ewing's sarcoma cells to topoisomerase II-targeting anticancer drugs

      CANCER RESEARCH
    15. Wang, SC; Makino, K; Su, LK; Pao, AY; Kim, JS; Hung, MC
      Ultraviolet irradiation induces BRCA2 protein depletion through a p53-independent and protein synthesis-dependent pathway

      CANCER RESEARCH
    16. Tsai, EM; Wang, SC; Lee, JN; Hung, MC
      Akt activation by estrogen in estrogen receptor-negative breast cancer cells

      CANCER RESEARCH
    17. Shao, RP; Tsai, EM; Wei, K; von Lindern, R; Chen, YH; Makino, K; Hung, MC
      E1A inhibition of radiation-induced NF-kappa B activity through suppression of IKK activity and I kappa B degradation, independent of Akt activation

      CANCER RESEARCH
    18. Wen, Y; Yan, DH; Wang, BL; Spohn, B; Ding, Y; Shao, RP; Zou, YY; Xie, KP; Hung, MC
      p202, an interferon-inducible protein, mediates multiple antitumor activities in human pancreatic cancer xenograft models

      CANCER RESEARCH
    19. Hung, MC; Shibasaki, K; Yoshida, R; Sato, M; Imaizumi, K
      Learning behaviour and cerebral protein kinase C, antioxidant status, lipid composition in senescence-accelerated mouse: influence of a phosphatidylcholine-vitamin B-12 diet

      BRITISH JOURNAL OF NUTRITION
    20. Xing, XM; Wang, SC; Xia, WY; Zou, YY; Shao, RP; Kwong, KY; Yu, ZM; Zhang, S; Miller, S; Huang, L; Hung, MC
      The Ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis

      NATURE MEDICINE
    21. Meric, F; Liao, Y; Lee, WP; Pollock, RE; Hung, MC
      Adenovirus 5 early region 1A does not induce expression of the Ewing sarcoma fusion product EWS-FLI1 in breast and ovarian cancer cell lines

      CLINICAL CANCER RESEARCH
    22. Ueno, NT; Bartholomeusz, C; Herrmann, JL; Estrov, Z; Shao, RP; Andreeff, M; Price, J; Paul, RW; Anklesaria, P; Yu, DH; Hung, MC
      E1A-mediated paclitaxel sensitization in HER-2/neu-overexpressing ovarian cancer SKOV3.ip1 through apoptosis involving the caspase-3 pathway

      CLINICAL CANCER RESEARCH
    23. Hung, MC; Shibasaki, K; Nishizono, S; Sato, M; Ikeda, I; Masuda, Y; Kunou, M; Kawamura, M; Yamashita, M; Inoue, S; Imaizumi, K
      Ibotenic acid-induced lesions of the medial septum increase hippocampal membrane associated protein kinase C activity and reduce acetylcholine synthesis: Prevention by a phosphatidylcholine/vitamin B-12 diet

      JOURNAL OF NUTRITIONAL BIOCHEMISTRY
    24. Lim, SJ; Lopez-Berestein, G; Hung, MC; Lupu, R; Tari, AM
      Grb2 downregulation leads to Akt inactivation in heregulin-stimulated and ErbB2-overexpressing breast cancer cells

      ONCOGENE
    25. Yu, DH; Hung, MC
      Overexpression of ErbB2 in cancer and ErbB2-targeting strategies

      ONCOGENE
    26. Xia, WY; Lau, YK; Hu, MCT; Li, L; Johnston, DA; Sheng, SJ; El-Naggar, AK; Hung, MC
      High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma

      ONCOGENE
    27. Yin, SM; Hung, MC; Goodrich, DW
      Adenovirus-mediated N5 gene transfer inhibits tumor cell proliferation by induction of apoptosis

      CANCER GENE THERAPY
    28. Sato, M; Yoshida, S; Nagao, K; Nishizono, S; Kusaba, M; Hung, MC; Ikeda, I; Imaizumi, K
      Application of the random arbitrary primed polymerase chain reaction differential display method to isolate genes of cholesterol metabolism-related proteins from rat liver

      BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
    29. Lee, RJ; Albanese, C; Fu, MF; D'Amico, M; Lin, B; Watanabe, G; Haines, GK; Siegel, PM; Hung, MC; Yarden, Y; Horowitz, JM; Muller, WJ; Pestell, RG
      Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway

      MOLECULAR AND CELLULAR BIOLOGY
    30. Yu, DH; Hung, MC
      Role of erbB2 in breast cancer chemosensitivity

      BIOESSAYS
    31. Shen, YC; Lo, KL; Chen, CY; Kuo, YH; Hung, MC
      New taxanes with an opened oxetane ring from the roots of Taxus mairei

      JOURNAL OF NATURAL PRODUCTS
    32. Hung, MC; Hortobagyi, GN; Ueno, NT
      Development of clinical trial of E1A gene therapy targeting HER-2/neu-overexpressing breast and ovarian cancer

      CANCER GENE THERAPY
    33. Lin, SY; Xia, WY; Wang, JC; Kwong, KY; Spohn, B; Wen, Y; Pestell, RG; Hung, MC
      beta-catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    34. Wang, SC; Hung, MC
      Transcriptional targeting of the HER-2/neu oncogene

      DRUGS OF TODAY
    35. Vadlamudi, RK; Adam, L; Wang, RA; Mandal, M; Nguyen, D; Sahin, A; Chernoff, J; Hung, MC; Kumar, R
      Regulatable expression of p21-activated kinase-1 promotes anchorage-independent growth and abnormal organization of mitotic spindles in human epithelial breast cancer cells

      JOURNAL OF BIOLOGICAL CHEMISTRY
    36. Yang, HY; Zhou, BHP; Hung, MC; Lee, MH
      Oncogenic signals of HER-2/neu in regulating the stability of the cyclin-dependent kinase inhibitor p27

      JOURNAL OF BIOLOGICAL CHEMISTRY
    37. Zhou, BP; Hu, MCT; Miller, SA; Yu, ZM; Xia, WY; Lin, SY; Hung, MC
      HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kappa B pathway

      JOURNAL OF BIOLOGICAL CHEMISTRY
    38. Shen, YC; Prakash, CVS; Hung, MC
      Taxane diterpenoids from the root bark of Taiwanese yew Taxus mairei

      JOURNAL OF THE CHINESE CHEMICAL SOCIETY
    39. Shen, YC; Hung, MC; Prakash, CVS; Wang, JJ
      New meroditerpenoids from A Taiwanese marine sponge Strongylophora durissima

      JOURNAL OF THE CHINESE CHEMICAL SOCIETY
    40. Shen, YC; Chen, CY; Hung, MC
      Taxane diterpenoids from seeds of Taxus mairei

      CHEMICAL & PHARMACEUTICAL BULLETIN
    41. Wen, Y; Hu, MCT; Makino, K; Spohn, B; Bartholomeusz, G; Yan, DH; Hung, MC
      HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway

      CANCER RESEARCH
    42. Xu, FJ; Xia, WY; Luo, RZ; Peng, HQ; Zhao, SL; Dai, JY; Long, Y; Zou, LL; Le, WD; Liu, JS; Parlow, AF; Hung, MC; Bast, RC; Yu, YH
      The human ARHI tumor suppressor gene inhibits lactation and growth in transgenic mice

      CANCER RESEARCH
    43. Shao, RP; Xia, WY; Hung, MC
      Inhibition of angiogenesis and induction of apoptosis are involved in E1A-mediated bystander effect and tumor suppression

      CANCER RESEARCH
    44. Wen, Y; Yan, DH; Spohn, B; Deng, J; Lin, SY; Hung, MC
      Tumor suppression and sensitization to tumor necrosis factor alpha-inducedapoptosis by an interferon-inducible protein, p202, in breast cancer cells

      CANCER RESEARCH
    45. Hung, MC
      Use of binomial group testing in tests of hypotheses for classification orquantitative covariables

      BIOMETRICS
    46. Hung, MC; Yan, DH; Zhang, S
      E1A-mediated gene therapy

      OVARIAN CANCER: METHODS AND PROTOCOLS
    47. Lin, SY; Hung, MC
      Cancer: Current concepts

      JOURNAL OF CLINICAL LIGAND ASSAY
    48. Hong, RL; Spohn, WH; Hung, MC
      Curcumin inhibits tyrosine kinase activity of p185(neu) and also depletes p185(neu1)

      CLINICAL CANCER RESEARCH
    49. Zhang, LS; Lau, YK; Xia, WY; Hortobagyi, GN; Hung, MC
      Tyrosine kinase inhibitor emodin suppresses growth of HER-2/neu-overexpressing breast cancer cells in athymic mice and sensitizes these cells to the inhibitory effect of paclitaxel

      CLINICAL CANCER RESEARCH
    50. Xia, WY; Lau, YK; Zhang, HZ; Xiao, FY; Johnston, DA; Liu, AR; Li, L; Katz, RL; Hung, MC
      Combination of EGFR, HER-2/neu, and HER-3 is a stronger predictor for the outcome of oral squamous cell carcinoma than any individual family members

      CLINICAL CANCER RESEARCH
    51. Ueno, NT; Xia, WY; Tucker, SD; Zhang, S; Lopez-Berestein, G; Huang, L; Hung, MC
      Issues in the development of gene therapy: Preclinical experiments in E1A gene delivery

      ONCOLOGY REPORTS
    52. Chang, WP; Hwang, JS; Hung, MC; Hu, TH; Lee, SD; Hwang, BF
      Chronic low-dose gamma-radiation exposure and the alteration of the distribution of lymphocyte subpopulations in residents of radioactive buildings

      INTERNATIONAL JOURNAL OF RADIATION BIOLOGY
    53. Tari, AM; Hung, MC; Li, KY; Lopez-Berestein, G
      Growth inhibition of breast cancer cells by Grb2 downregulation is correlated with inactivation of mitogen-activated protein kinase in EGFR, but not in ErbB2, cells

      ONCOGENE
    54. Lu, YL; Lin, YZ; LaPushin, R; Cuevas, B; Fang, XJ; Yu, SX; Davies, MA; Khan, H; Furui, T; Mao, ML; Zinner, R; Hung, MC; Steck, P; Siminovitch, K; Mills, GB
      The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and inducesapoptosis and anoikis in breast cancer cells

      ONCOGENE
    55. Yan, DH; Wen, Y; Spohn, B; Choubey, D; Gutterman, JU; Hung, MC
      Reduced growth rate and transformation phenotype of the prostate cancer cells by an interferon-inducible protein, p202

      ONCOGENE
    56. Li, KY; Shao, RP; Hung, MC
      Collagen-homology domain 1 deletion mutant of Shc suppresses transformation mediated by neu through a MAPK-independent pathway

      ONCOGENE
    57. Lo, SS; Lo, SH; Wang, SC; Hung, MC
      Inhibition of focal contact formation in cells transformed by p185(neu)

      MOLECULAR CARCINOGENESIS
    58. Lee, WP; Liao, Y; Robinson, D; Kung, HJ; Liu, ET; Hung, MC
      Ax1-Gas6 interaction counteracts E1A-mediated cell growth suppression and proapoptotic activity

      MOLECULAR AND CELLULAR BIOLOGY
    59. Hortobagyi, GN; Hung, MC; Buzdar, AU
      Regcent developments in breast cancer therapy

      SEMINARS IN ONCOLOGY
    60. Hung, MC; Lau, YK
      Basic science of HER-2/neu: A review

      SEMINARS IN ONCOLOGY
    61. Shao, RP; Hu, MCT; Zhou, BHP; Lin, SY; Chiao, PJ; von Lindern, RH; Spohn, B; Hung, MC
      E1A sensitizes cells to tumor necrosis factor-induced apoptosis through inhibition of I kappa B kinases and nuclear factor kappa B activities

      JOURNAL OF BIOLOGICAL CHEMISTRY
    62. Yu, DH; Hung, MC
      Translational research in breast cancer

      BREAST CANCER
    63. YU DH; JING T; LIU BL; YAO J; TAN M; MCDONNELL TJ; HUNG MC
      OVEREXPRESSION OF ERBB2 BLOCKS TAXOL-INDUCED APOPTOSIS BY UP-REGULATION OF P21(CIP1), WHICH INHIBITS P34(CDC2) KINASE

      MOLECULAR CELL
    64. HORTOBAGYI GN; HUNG MC
      A PHASE-I MULTICENTER STUDY OF E1A GENE-THERAPY FOR PATIENTS WITH METASTATIC BREAST-CANCER AND EPITHELIAL OVARIAN-CANCER THAT OVEREXPRESSESHER-2 NEU OR EPITHELIAL OVARIAN-CANCER/

      Human gene therapy
    65. XING X; ZHANG S; CHANG JY; TUCKER SD; CHEN H; HUANG L; HUNG MC
      SAFETY STUDY AND CHARACTERIZATION OF E1A-LIPOSOME COMPLEX GENE-DELIVERY PROTOCOL IN AN OVARIAN-CANCER MODEL

      Gene therapy
    66. SU LK; WANG SC; QI Y; LUO WP; HUNG MC; LIN SH
      CHARACTERIZATION OF BRCA2 - TEMPERATURE SENSITIVITY OF DETECTION AND CELL-CYCLE-REGULATED EXPRESSION

      Oncogene
    67. DENG J; XIA WY; HUNG MC
      ADENOVIRUS-5 E1A-MEDIATED TUMOR SUPPRESSION ASSOCIATED WITH E1A-MEDIATED APOPTOSIS IN-VIVO

      Oncogene
    68. ZHANG LS; LAU YK; XI L; HONG RL; KIM DS; CHEN CF; HORTOBAGYI GN; CHANG CJ; HUNG MC
      TYROSINE KINASE INHIBITORS, EMODIN AND ITS DERIVATIVE REPRESS HER-2 NEU-INDUCED CELLULAR-TRANSFORMATION AND METASTASIS-ASSOCIATED PROPERTIES/

      Oncogene
    69. YU DH; LIU BL; JING T; SUN DT; PRICE JE; SINGLETARY SE; IBRAHIM N; HORTOBAGYI GN; HUNG MC
      OVEREXPRESSION OF BOTH P185(C-ERBB2) AND P170(MDR-1) RENDERS BREAST-CANCER CELLS HIGHLY RESISTANT TO TAXOL

      Oncogene
    70. LE XF; VALLIAN S; MU ZM; HUNG MC; CHANG KS
      RECOMBINANT PML ADENOVIRUS SUPPRESSES GROWTH AND TUMORIGENICITY OF HUMAN BREAST-CANCER CELLS BY INDUCING G1 CELL-CYCLE ARREST AND APOPTOSIS

      Oncogene
    71. KWONG KY; HUNG MC
      A NOVEL SPLICE VARIANT OF HER2 WITH INCREASED TRANSFORMATION ACTIVITY

      Molecular carcinogenesis (Print)
    72. HUNG MC; CHANG JYJ; XING XM
      PRECLINICAL AND CLINICAL-STUDY OF HER-2 NEU-TARGETING CANCER GENE-THERAPY/

      Advanced drug delivery reviews
    73. YU DH; HUNG MC
      THE ERBB2 GENE AS A CANCER THERAPEUTIC TARGET AND THE TUMOR-SUPPRESSING AND METASTASIS-SUPPRESSING FUNCTION OF E1A

      Cancer metastasis reviews
    74. CHEN SJ; HWANG WI; CHIU SC; HUNG MC; LIN CC
      SIZE DISTRIBUTION OF PARTICLE-BOUND PAH COMPOSITION IN THE AMBIENT AIR OF BUS STATION

      Journal of environmental science and health. Part A: Environmental science and engineering
    75. BRADER KR; WOLF JK; HUNG MC; YU DH; CRISPENS MA; VANGOLEN KL; PRICE JE
      ADENOVIRUS E1A EXPRESSION ENHANCES THE SENSITIVITY OF AN OVARIAN-CANCER CELL-LINE TO MULTIPLE CYTOTOXIC AGENTS THROUGH AN APOPTOTIC MECHANISM

      Clinical cancer research
    76. XIA WY; LAU YK; ZHANG HZ; LIU AR; LI L; KIYOKAWA N; CLAYMAN GL; KATZ RL; HUNG MC
      STRONG CORRELATION BETWEEN C-ERBB-2 OVEREXPRESSION AND OVERALL SURVIVAL OF PATIENTS WITH ORAL SQUAMOUS-CELL CARCINOMA

      Clinical cancer research
    77. BOURGUIGNON LYW; ZHU H; CHU A; IIDA N; ZHANG L; HUNG MC
      INTERACTION BETWEEN CD44 AND P185(HER2) PROMOTES HUMAN OVARIAN TUMOR-CELL ACTIVATION

      Molecular biology of the cell
    78. XING X; LIU V; XIA W; STEPHENS LC; HUANG L; LOPEZBERESTEIN G; HUNG MC
      SAFETY STUDIES OF THE INTRAPERITONEAL INJECTION OF E1A-LIPOSOME COMPLEX IN MICE

      Gene therapy
    79. UENO NT; YU DH; HUNG MC
      CHEMOSENSITIZATION OF HER-2 NEU-OVEREXPRESSING HUMAN BREAST-CANCER CELLS TO PACLITAXEL (TAXOL) BY ADENOVIRUS TYPE-5 E1A/

      Oncogene
    80. KIYOKAWA N; KARUNAGARAN D; LEE EK; XIE YM; YAN DH; HUNG MC
      INVOLVEMENT OF CDC2-MEDIATED PHOSPHORYLATION IN THE CELL CYCLE-DEPENDENT REGULATION OF P185(NEU)

      Oncogene
    81. CHANG JY; XIA WY; SHAO RP; SORGI F; HORTOBAGYI GN; HUANG L; HUNG MC
      THE TUMOR SUPPRESSION ACTIVITY OF E1A IN HER-2 NEU-OVEREXPRESSING BREAST-CANCER/

      Oncogene
    82. CHEN H; YU DH; CHINNADURAI G; KARUNAGARAN D; HUNG MC
      MAPPING OF ADENOVIRUS-5 E1A-DOMAINS RESPONSIBLE FOR SUPPRESSION OF NEU-MEDIATED TRANSFORMATION VIA TRANSCRIPTIONAL REPRESSION OF NEU

      Oncogene
    83. LUO WP; WOOD CG; EARLEY K; HUNG MC; LIN SH
      SUPPRESSION OF TUMORIGENICITY OF BREAST-CANCER CELLS BY AN EPITHELIAL-CELL ADHESION MOLECULE (C-CAM1) - THE ADHESION AND GROWTH SUPPRESSIONARE MEDIATED BY DIFFERENT DOMAINS

      Oncogene
    84. LOOMIS A; ZHANG S; LAFOE D; NGUYEN T; SLOANE DL; HUNG MC; PAUL R
      OPTIMIZATION OF CATIONIC LIPID-PROTAMINE SULFATE - DNA RATIOS FOR IMPROVED STABILITY AND GENE-TRANSFER TO TUMORS

      Cancer gene therapy
    85. SHAO RP; KARUNAGARAN D; ZHOU BHP; LI KY; LO SS; DENG J; CHIAO P; HUNG MC
      INHIBITION OF NUCLEAR FACTOR-KAPPA-B ACTIVITY IS INVOLVED IN E1A-MEDIATED SENSITIZATION OF RADIATION-INDUCED APOPTOSIS

      The Journal of biological chemistry
    86. BOURGUIGNON LYW; ZHU HB; CHU A; IIDA N; ZHANG L; HUNG MC
      INTERACTION BETWEEN THE ADHESION RECEPTOR, CD44, AND THE ONCOGENE PRODUCT, P185(HER2), PROMOTES HUMAN OVARIAN TUMOR-CELL ACTIVATION

      The Journal of biological chemistry
    87. KIYOKAWA N; LEE EK; KARUNAGARAN D; LIN SY; HUNG MC
      MITOSIS-SPECIFIC NEGATIVE REGULATION OF EPIDERMAL GROWTH-FACTOR RECEPTOR, TRIGGERED BY A DECREASE IN LIGAND-BINDING AND DIMERIZATION, CAN BE OVERCOME BY OVEREXPRESSION OF RECEPTOR

      The Journal of biological chemistry
    88. CHEN H; HUNG MC
      INVOLVEMENT OF COACTIVATOR P300 IN THE TRANSCRIPTIONAL REGULATION OF THE HER-2 NEU GENE/

      The Journal of biological chemistry
    89. HWANG JS; CHOU WY; HUNG MC; WANG JS; LIN HH
      BUILT-IN ELECTRIC-FIELD AND SURFACE FERMI-LEVEL IN INP SURFACE-INTRINSIC N(+) STRUCTURES BY MODULATION SPECTROSCOPY

      Journal of applied physics
    90. HUNT KK; DENG J; LIU TJ; WILSONHEINER M; SWISHER SG; CLAYMAN G; HUNG MC
      ADENOVIRUS-MEDIATED OVEREXPRESSION OF THE TRANSCRIPTION FACTOR E2F-1 INDUCES APOPTOSIS IN HUMAN BREAST AND OVARIAN-CARCINOMA CELL-LINES ANDDOES NOT REQUIRE P53

      Cancer research
    91. WANG SC; LIN SH; SU LK; HUNG MC
      CHANGES IN BRCA2 EXPRESSION DURING PROGRESSION OF THE CELL-CYCLE

      Biochemical and biophysical research communications
    92. PETIT AMV; RAK J; HUNG MC; ROCKWELL P; GOLDSTEIN N; FENDLY B; KERBEL RS
      NEUTRALIZING ANTIBODIES AGAINST EPIDERMAL GROWTH-FACTOR AND ERBB-2 NEU RECEPTOR TYROSINE KINASES DOWN-REGULATE VASCULAR ENDOTHELIAL GROWTH-FACTOR PRODUCTION BY TUMOR-CELLS IN-VITRO AND IN-VIVO - ANGIOGENIC IMPLICATIONS FOR SIGNAL-TRANSDUCTION THERAPY OF SOLID TUMORS/

      The American journal of pathology
    93. GERSHENSON DM; BAKER VV; PRICE JE; HUNG MC; ELNAGGAR AK; TORTOLEROLUNA G; SILVA EG
      MOLECULAR PROFILE OF ADVANCED-STAGE TRANSITIONAL-CELL CARCINOMA OF THE OVARY

      American journal of obstetrics and gynecology
    94. LIU BL; SUN DT; XIA WY; HUNG MC; YU DH
      CROSS-REACTIVITY OF C219 ANTI-P170(MDR-1) ANTIBODY WITH P185(C-ERBB2)IN BREAST-CANCER CELLS - CAUTIONS ON EVALUATING P170(MDR-1)

      Journal of the National Cancer Institute
    95. MILLER SJ; XING XM; XI L; HUNG MC
      IDENTIFICATION OF A SPECIFIC DNA REGION REQUIRED FOR ENHANCED TRANSCRIPTION OF HER2 NEU IN THE MDA-MB453 BREAST-CANCER CELL-LINE/

      DNA and cell biology
    96. RUSSELL KS; LEE EK; KIYOKAWA N; HIDEYUKI S; HUNG MC
      EFFECTS OF ESTROGEN-RECEPTOR EXPRESSION ON GROWTH AND TRANSFORMATION OF CELLS OVEREXPRESSING NEU

      Oncology Reports
    97. UENO NT; KIYOKAWA N; HUNG MC
      GROWTH SUPPRESSION OF LOW HER-2 NEU-EXPRESSING BREAST-CANCER CELL-LINE MDA-MB-435 BY TYROSINE KINASE INHIBITOR EMODIN/

      Oncology Reports
    98. CHANG JY; XIA WY; SHAO RP; HUNG MC
      INHIBITION OF INTRATRACHEAL LUNG-CANCER DEVELOPMENT BY SYSTEMIC DELIVERY OF E1A

      Oncogene
    99. YU DH; LIU BL; TAN M; LI JZ; WANG SS; HUNG MC
      OVEREXPRESSION OF C-ERBB-2 NEU IN BREAST-CANCER CELLS CONFERS INCREASED RESISTANCE TO TAXOL VIA MDR-1-INDEPENDENT MECHANISMS/

      Oncogene
    100. ZHANG LS; HUNG MC
      SENSITIZATION OF HER-2 NEU-OVEREXPRESSING NON-SMALL-CELL LUNG-CANCER CELLS TO CHEMOTHERAPEUTIC DRUGS BY TYROSINE KINASE INHIBITOR EMODIN/

      Oncogene


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 02/06/20 alle ore 20:44:59